David M Burger

Suggest Changes
Learn More
BACKGROUND Single-dose nevirapine is a highly cost-effective strategy to reduce perinatal HIV-1 transmission. Its major disadvantage is the selection of nevirapine resistance in 20% to 30% of women,(More)